Phase I study of single-agent CC-292, a highly selective Bruton's tyrosine kinase inhibitor, in relapsed/refractory chronic lymphocytic leukemia
| Image |  |
|---|---|
| Description | scientific article published on 5 May 2016 |
| Author/s |
author: Janice Gabrilove |
| Publication date | May 5, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |